List of Tables
Table 1. Global Osteoarthritis Pain Drugs Market Value by Type (US$ Million), 2025 vs 2032
Table 2. Global Osteoarthritis Pain Drugs Market Value by Application (US$ Million), 2025 vs 2032
Table 3. Global Osteoarthritis Pain Drugs Market Competitive Situation by Manufacturers in 2025
Table 4. Global Osteoarthritis Pain Drugs Sales (K Units) of Key Manufacturers (2021–2026)
Table 5. Global Osteoarthritis Pain Drugs Sales Market Share by Manufacturers (2021–2026)
Table 6. Global Osteoarthritis Pain Drugs Revenue (US$ Million) by Manufacturers (2021–2026)
Table 7. Global Osteoarthritis Pain Drugs Revenue Share by Manufacturers (2021–2026)
Table 8. Global Market Osteoarthritis Pain Drugs Average Price (USD/Unit) of Key Manufacturers (2021–2026)
Table 9. Global Key Players of Osteoarthritis Pain Drugs, Industry Ranking, 2023 vs 2024 vs 2025
Table 10. Global Key Manufacturers of Osteoarthritis Pain Drugs, Manufacturing Sites and Headquarters
Table 11. Global Key Manufacturers of Osteoarthritis Pain Drugs, Product Types and Applications
Table 12. Global Key Manufacturers of Osteoarthritis Pain Drugs, Date of Entry into the Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Osteoarthritis Pain Drugs Companies by Tier (Tier 1, Tier 2, Tier 3), based on Osteoarthritis Pain Drugs Revenue, 2025
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Osteoarthritis Pain Drugs Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Table 17. Global Osteoarthritis Pain Drugs Sales by Region (K Units), 2021–2026
Table 18. Global Osteoarthritis Pain Drugs Sales Market Share by Region (2021–2026)
Table 19. Global Osteoarthritis Pain Drugs Sales by Region (K Units), 2027–2032
Table 20. Global Osteoarthritis Pain Drugs Sales Market Share by Region (2027–2032)
Table 21. Global Osteoarthritis Pain Drugs Revenue by Region (US$ Million), 2021–2026
Table 22. Global Osteoarthritis Pain Drugs Revenue Market Share by Region (2021–2026)
Table 23. Global Osteoarthritis Pain Drugs Revenue by Region (US$ Million), 2027–2032
Table 24. Global Osteoarthritis Pain Drugs Revenue Market Share by Region (2027–2032)
Table 25. North America Osteoarthritis Pain Drugs Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 26. North America Osteoarthritis Pain Drugs Sales by Country (K Units), 2021–2026
Table 27. North America Osteoarthritis Pain Drugs Sales by Country (K Units), 2027–2032
Table 28. North America Osteoarthritis Pain Drugs Revenue by Country (US$ Million), 2021–2026
Table 29. North America Osteoarthritis Pain Drugs Revenue by Country (US$ Million), 2027–2032
Table 30. Europe Osteoarthritis Pain Drugs Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 31. Europe Osteoarthritis Pain Drugs Sales by Country (K Units), 2021–2026
Table 32. Europe Osteoarthritis Pain Drugs Sales by Country (K Units), 2027–2032
Table 33. Europe Osteoarthritis Pain Drugs Revenue by Country (US$ Million), 2021–2026
Table 34. Europe Osteoarthritis Pain Drugs Revenue by Country (US$ Million), 2027–2032
Table 35. Asia Pacific Osteoarthritis Pain Drugs Revenue by Region: 2021 vs 2025 vs 2032 (US$ Million)
Table 36. Asia Pacific Osteoarthritis Pain Drugs Sales by Region (K Units), 2021–2026
Table 37. Asia Pacific Osteoarthritis Pain Drugs Sales by Region (K Units), 2027–2032
Table 38. Asia Pacific Osteoarthritis Pain Drugs Revenue by Region (US$ Million), 2021–2026
Table 39. Asia Pacific Osteoarthritis Pain Drugs Revenue by Region (US$ Million), 2027–2032
Table 40. Latin America Osteoarthritis Pain Drugs Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 41. Latin America Osteoarthritis Pain Drugs Sales by Country (K Units), 2021–2026
Table 42. Latin America Osteoarthritis Pain Drugs Sales by Country (K Units), 2027–2032
Table 43. Latin America Osteoarthritis Pain Drugs Revenue by Country (US$ Million), 2021–2026
Table 44. Latin America Osteoarthritis Pain Drugs Revenue by Country (US$ Million), 2027–2032
Table 45. Middle East and Africa Osteoarthritis Pain Drugs Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 46. Middle East and Africa Osteoarthritis Pain Drugs Sales by Country (K Units), 2021–2026
Table 47. Middle East and Africa Osteoarthritis Pain Drugs Sales by Country (K Units), 2027–2032
Table 48. Middle East and Africa Osteoarthritis Pain Drugs Revenue by Country (US$ Million), 2021–2026
Table 49. Middle East and Africa Osteoarthritis Pain Drugs Revenue by Country (US$ Million), 2027–2032
Table 50. Global Osteoarthritis Pain Drugs Sales (K Units) by Type (2021–2026)
Table 51. Global Osteoarthritis Pain Drugs Sales (K Units) by Type (2027–2032)
Table 52. Global Osteoarthritis Pain Drugs Sales Market Share by Type (2021–2026)
Table 53. Global Osteoarthritis Pain Drugs Sales Market Share by Type (2027–2032)
Table 54. Global Osteoarthritis Pain Drugs Revenue (US$ Million) by Type (2021–2026)
Table 55. Global Osteoarthritis Pain Drugs Revenue (US$ Million) by Type (2027–2032)
Table 56. Global Osteoarthritis Pain Drugs Revenue Market Share by Type (2021–2026)
Table 57. Global Osteoarthritis Pain Drugs Revenue Market Share by Type (2027–2032)
Table 58. Global Osteoarthritis Pain Drugs Price (USD/Unit) by Type (2021–2026)
Table 59. Global Osteoarthritis Pain Drugs Price (USD/Unit) by Type (2027–2032)
Table 60. Global Osteoarthritis Pain Drugs Sales (K Units) by Application (2021–2026)
Table 61. Global Osteoarthritis Pain Drugs Sales (K Units) by Application (2027–2032)
Table 62. Global Osteoarthritis Pain Drugs Sales Market Share by Application (2021–2026)
Table 63. Global Osteoarthritis Pain Drugs Sales Market Share by Application (2027–2032)
Table 64. Global Osteoarthritis Pain Drugs Revenue (US$ Million) by Application (2021–2026)
Table 65. Global Osteoarthritis Pain Drugs Revenue (US$ Million) by Application (2027–2032)
Table 66. Global Osteoarthritis Pain Drugs Revenue Market Share by Application (2021–2026)
Table 67. Global Osteoarthritis Pain Drugs Revenue Market Share by Application (2027–2032)
Table 68. Global Osteoarthritis Pain Drugs Price (USD/Unit) by Application (2021–2026)
Table 69. Global Osteoarthritis Pain Drugs Price (USD/Unit) by Application (2027–2032)
Table 70. Pfizer Company Information
Table 71. Pfizer Description and Business Overview
Table 72. Pfizer Osteoarthritis Pain Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit), and Gross Margin (2021–2026)
Table 73. Pfizer Osteoarthritis Pain Drugs Product
Table 74. Pfizer Recent Developments/Updates
Table 75. Bayer Company Information
Table 76. Bayer Description and Business Overview
Table 77. Bayer Osteoarthritis Pain Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit), and Gross Margin (2021–2026)
Table 78. Bayer Osteoarthritis Pain Drugs Product
Table 79. Bayer Recent Developments/Updates
Table 80. SK Chemicals Company Information
Table 81. SK Chemicals Description and Business Overview
Table 82. SK Chemicals Osteoarthritis Pain Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit), and Gross Margin (2021–2026)
Table 83. SK Chemicals Osteoarthritis Pain Drugs Product
Table 84. SK Chemicals Recent Developments/Updates
Table 85. GSK Company Information
Table 86. GSK Description and Business Overview
Table 87. GSK Osteoarthritis Pain Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit), and Gross Margin (2021–2026)
Table 88. GSK Osteoarthritis Pain Drugs Product
Table 89. GSK Recent Developments/Updates
Table 90. Sanofi Company Information
Table 91. Sanofi Description and Business Overview
Table 92. Sanofi Osteoarthritis Pain Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit), and Gross Margin (2021–2026)
Table 93. Sanofi Osteoarthritis Pain Drugs Product
Table 94. Sanofi Recent Developments/Updates
Table 95. Crystal Genomics Company Information
Table 96. Crystal Genomics Description and Business Overview
Table 97. Crystal Genomics Osteoarthritis Pain Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit), and Gross Margin (2021–2026)
Table 98. Crystal Genomics Osteoarthritis Pain Drugs Product
Table 99. Crystal Genomics Recent Developments/Updates
Table 100. Johnson & Johnson Company Information
Table 101. Johnson & Johnson Description and Business Overview
Table 102. Johnson & Johnson Osteoarthritis Pain Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit), and Gross Margin (2021–2026)
Table 103. Johnson & Johnson Osteoarthritis Pain Drugs Product
Table 104. Johnson & Johnson Recent Developments/Updates
Table 105. Sino Biopharmaceutical Company Information
Table 106. Sino Biopharmaceutical Description and Business Overview
Table 107. Sino Biopharmaceutical Osteoarthritis Pain Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit), and Gross Margin (2021–2026)
Table 108. Sino Biopharmaceutical Osteoarthritis Pain Drugs Product
Table 109. Sino Biopharmaceutical Recent Developments/Updates
Table 110. Haohai Biological Company Information
Table 111. Haohai Biological Description and Business Overview
Table 112. Haohai Biological Osteoarthritis Pain Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit), and Gross Margin (2021–2026)
Table 113. Haohai Biological Osteoarthritis Pain Drugs Product
Table 114. Haohai Biological Recent Developments/Updates
Table 115. Zhejiang Chengyi Pharmaceutical Company Information
Table 116. Zhejiang Chengyi Pharmaceutical Description and Business Overview
Table 117. Zhejiang Chengyi Pharmaceutical Osteoarthritis Pain Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit), and Gross Margin (2021–2026)
Table 118. Zhejiang Chengyi Pharmaceutical Osteoarthritis Pain Drugs Product
Table 119. Zhejiang Chengyi Pharmaceutical Recent Developments/Updates
Table 120. Freda Company Information
Table 121. Freda Description and Business Overview
Table 122. Freda Osteoarthritis Pain Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit), and Gross Margin (2021–2026)
Table 123. Freda Osteoarthritis Pain Drugs Product
Table 124. Freda Recent Developments/Updates
Table 125. Bright Future Company Information
Table 126. Bright Future Description and Business Overview
Table 127. Bright Future Osteoarthritis Pain Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit), and Gross Margin (2021–2026)
Table 128. Bright Future Osteoarthritis Pain Drugs Product
Table 129. Bright Future Recent Developments/Updates
Table 130. Jingfeng Pharmaceutical Company Information
Table 131. Jingfeng Pharmaceutical Description and Business Overview
Table 132. Jingfeng Pharmaceutical Osteoarthritis Pain Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit), and Gross Margin (2021–2026)
Table 133. Jingfeng Pharmaceutical Osteoarthritis Pain Drugs Product
Table 134. Jingfeng Pharmaceutical Recent Developments/Updates
Table 135. Chugai Pharmaceutical Company Information
Table 136. Chugai Pharmaceutical Description and Business Overview
Table 137. Chugai Pharmaceutical Osteoarthritis Pain Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit), and Gross Margin (2021–2026)
Table 138. Chugai Pharmaceutical Osteoarthritis Pain Drugs Product
Table 139. Chugai Pharmaceutical Recent Developments/Updates
Table 140. Mikasa Seiyaku Company Information
Table 141. Mikasa Seiyaku Description and Business Overview
Table 142. Mikasa Seiyaku Osteoarthritis Pain Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit), and Gross Margin (2021–2026)
Table 143. Mikasa Seiyaku Osteoarthritis Pain Drugs Product
Table 144. Mikasa Seiyaku Recent Developments/Updates
Table 145. Taisho Pharmaceutical Company Information
Table 146. Taisho Pharmaceutical Description and Business Overview
Table 147. Taisho Pharmaceutical Osteoarthritis Pain Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit), and Gross Margin (2021–2026)
Table 148. Taisho Pharmaceutical Osteoarthritis Pain Drugs Product
Table 149. Taisho Pharmaceutical Recent Developments/Updates
Table 150. Seikagaku Corporation Company Information
Table 151. Seikagaku Corporation Description and Business Overview
Table 152. Seikagaku Corporation Osteoarthritis Pain Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit), and Gross Margin (2021–2026)
Table 153. Seikagaku Corporation Osteoarthritis Pain Drugs Product
Table 154. Seikagaku Corporation Recent Developments/Updates
Table 155. GlaxoSmithKline Company Information
Table 156. GlaxoSmithKline Description and Business Overview
Table 157. GlaxoSmithKline Osteoarthritis Pain Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit), and Gross Margin (2021–2026)
Table 158. GlaxoSmithKline Osteoarthritis Pain Drugs Product
Table 159. GlaxoSmithKline Recent Developments/Updates
Table 160. Eli Lilly Company Information
Table 161. Eli Lilly Description and Business Overview
Table 162. Eli Lilly Osteoarthritis Pain Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit), and Gross Margin (2021–2026)
Table 163. Eli Lilly Osteoarthritis Pain Drugs Product
Table 164. Eli Lilly Recent Developments/Updates
Table 165. Novartis Company Information
Table 166. Novartis Description and Business Overview
Table 167. Novartis Osteoarthritis Pain Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit), and Gross Margin (2021–2026)
Table 168. Novartis Osteoarthritis Pain Drugs Product
Table 169. Novartis Recent Developments/Updates
Table 170. Horizon Pharma Company Information
Table 171. Horizon Pharma Description and Business Overview
Table 172. Horizon Pharma Osteoarthritis Pain Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit), and Gross Margin (2021–2026)
Table 173. Horizon Pharma Osteoarthritis Pain Drugs Product
Table 174. Horizon Pharma Recent Developments/Updates
Table 175. Abbott Company Information
Table 176. Abbott Description and Business Overview
Table 177. Abbott Osteoarthritis Pain Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit), and Gross Margin (2021–2026)
Table 178. Abbott Osteoarthritis Pain Drugs Product
Table 179. Abbott Recent Developments/Updates
Table 180. Mylan Company Information
Table 181. Mylan Description and Business Overview
Table 182. Mylan Osteoarthritis Pain Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit), and Gross Margin (2021–2026)
Table 183. Mylan Osteoarthritis Pain Drugs Product
Table 184. Mylan Recent Developments/Updates
Table 185. Daiichi Sankyo Company Information
Table 186. Daiichi Sankyo Description and Business Overview
Table 187. Daiichi Sankyo Osteoarthritis Pain Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit), and Gross Margin (2021–2026)
Table 188. Daiichi Sankyo Osteoarthritis Pain Drugs Product
Table 189. Daiichi Sankyo Recent Developments/Updates
Table 190. TEVA Company Information
Table 191. TEVA Description and Business Overview
Table 192. TEVA Osteoarthritis Pain Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit), and Gross Margin (2021–2026)
Table 193. TEVA Osteoarthritis Pain Drugs Product
Table 194. TEVA Recent Developments/Updates
Table 195. Almatica Pharma Company Information
Table 196. Almatica Pharma Description and Business Overview
Table 197. Almatica Pharma Osteoarthritis Pain Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit), and Gross Margin (2021–2026)
Table 198. Almatica Pharma Osteoarthritis Pain Drugs Product
Table 199. Almatica Pharma Recent Developments/Updates
Table 200. Astellas Pharma Company Information
Table 201. Astellas Pharma Description and Business Overview
Table 202. Astellas Pharma Osteoarthritis Pain Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit), and Gross Margin (2021–2026)
Table 203. Astellas Pharma Osteoarthritis Pain Drugs Product
Table 204. Astellas Pharma Recent Developments/Updates
Table 205. Tide Pharmaceutical Company Information
Table 206. Tide Pharmaceutical Description and Business Overview
Table 207. Tide Pharmaceutical Osteoarthritis Pain Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit), and Gross Margin (2021–2026)
Table 208. Tide Pharmaceutical Osteoarthritis Pain Drugs Product
Table 209. Tide Pharmaceutical Recent Developments/Updates
Table 210. Iroko Pharmaceuticals Company Information
Table 211. Iroko Pharmaceuticals Description and Business Overview
Table 212. Iroko Pharmaceuticals Osteoarthritis Pain Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit), and Gross Margin (2021–2026)
Table 213. Iroko Pharmaceuticals Osteoarthritis Pain Drugs Product
Table 214. Iroko Pharmaceuticals Recent Developments/Updates
Table 215. Hengrui Pharmaceutical Company Information
Table 216. Hengrui Pharmaceutical Description and Business Overview
Table 217. Hengrui Pharmaceutical Osteoarthritis Pain Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit), and Gross Margin (2021–2026)
Table 218. Hengrui Pharmaceutical Osteoarthritis Pain Drugs Product
Table 219. Hengrui Pharmaceutical Recent Developments/Updates
Table 220. Key Raw Materials Lists
Table 221. Raw Materials Key Suppliers Lists
Table 222. Osteoarthritis Pain Drugs Distributors List
Table 223. Osteoarthritis Pain Drugs Customers List
Table 224. Osteoarthritis Pain Drugs Market Trends
Table 225. Osteoarthritis Pain Drugs Market Drivers
Table 226. Osteoarthritis Pain Drugs Market Challenges
Table 227. Osteoarthritis Pain Drugs Market Restraints
Table 228. Research Programs/Design for This Report
Table 229. Key Data Information from Secondary Sources
Table 230. Key Data Information from Primary Sources
Table 231. Authors List of This Report
List of Figures
Figure 1. Product Picture of Osteoarthritis Pain Drugs
Figure 2. Global Osteoarthritis Pain Drugs Market Value by Type (US$ Million), 2021–2032
Figure 3. Global Osteoarthritis Pain Drugs Market Share by Type: 2025 & 2032
Figure 4. Oral Product Picture
Figure 5. Injection Product Picture
Figure 6. External Product Picture
Figure 7. Global Osteoarthritis Pain Drugs Market Value by Application (US$ Million), 2021–2032
Figure 8. Global Osteoarthritis Pain Drugs Market Share by Application: 2025 & 2032
Figure 9. Medical Care
Figure 10. Personal Care
Figure 11. Global Osteoarthritis Pain Drugs Revenue, (US$ Million), 2021 vs 2025 vs 2032
Figure 12. Global Osteoarthritis Pain Drugs Market Size (US$ Million), 2021–2032
Figure 13. Global Osteoarthritis Pain Drugs Sales (K Units), 2021–2032
Figure 14. Global Osteoarthritis Pain Drugs Average Price (USD/Unit), 2021–2032
Figure 15. Osteoarthritis Pain Drugs Report Years Considered
Figure 16. Osteoarthritis Pain Drugs Sales Share by Manufacturers in 2025
Figure 17. Global Osteoarthritis Pain Drugs Revenue Share by Manufacturers in 2025
Figure 18. Top 5 and Top 10 Global Osteoarthritis Pain Drugs Players: Market Share by Revenue in Osteoarthritis Pain Drugs in 2025
Figure 19. Osteoarthritis Pain Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2021 vs 2025
Figure 20. Global Osteoarthritis Pain Drugs Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Figure 21. North America Osteoarthritis Pain Drugs Sales Market Share by Country (2021–2032)
Figure 22. North America Osteoarthritis Pain Drugs Revenue Market Share by Country (2021–2032)
Figure 23. U.S. Osteoarthritis Pain Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 24. Canada Osteoarthritis Pain Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 25. Europe Osteoarthritis Pain Drugs Sales Market Share by Country (2021–2032)
Figure 26. Europe Osteoarthritis Pain Drugs Revenue Market Share by Country (2021–2032)
Figure 27. Germany Osteoarthritis Pain Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 28. France Osteoarthritis Pain Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 29. U.K. Osteoarthritis Pain Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 30. Italy Osteoarthritis Pain Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 31. Russia Osteoarthritis Pain Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 32. Asia Pacific Osteoarthritis Pain Drugs Sales Market Share by Region (2021–2032)
Figure 33. Asia Pacific Osteoarthritis Pain Drugs Revenue Market Share by Region (2021–2032)
Figure 34. China Osteoarthritis Pain Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 35. Japan Osteoarthritis Pain Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 36. South Korea Osteoarthritis Pain Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 37. India Osteoarthritis Pain Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 38. Australia Osteoarthritis Pain Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 39. China Taiwan Osteoarthritis Pain Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 40. Indonesia Osteoarthritis Pain Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 41. Thailand Osteoarthritis Pain Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 42. Malaysia Osteoarthritis Pain Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 43. Latin America Osteoarthritis Pain Drugs Sales Market Share by Country (2021–2032)
Figure 44. Latin America Osteoarthritis Pain Drugs Revenue Market Share by Country (2021–2032)
Figure 45. Mexico Osteoarthritis Pain Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 46. Brazil Osteoarthritis Pain Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 47. Argentina Osteoarthritis Pain Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 48. Middle East and Africa Osteoarthritis Pain Drugs Sales Market Share by Country (2021–2032)
Figure 49. Middle East and Africa Osteoarthritis Pain Drugs Revenue Market Share by Country (2021–2032)
Figure 50. Turkey Osteoarthritis Pain Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 51. Saudi Arabia Osteoarthritis Pain Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 52. UAE Osteoarthritis Pain Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 53. Global Sales Market Share of Osteoarthritis Pain Drugs by Type (2021–2032)
Figure 54. Global Revenue Market Share of Osteoarthritis Pain Drugs by Type (2021–2032)
Figure 55. Global Osteoarthritis Pain Drugs Price (USD/Unit) by Type (2021–2032)
Figure 56. Global Sales Market Share of Osteoarthritis Pain Drugs by Application (2021–2032)
Figure 57. Global Revenue Market Share of Osteoarthritis Pain Drugs by Application (2021–2032)
Figure 58. Global Osteoarthritis Pain Drugs Price (USD/Unit) by Application (2021–2032)
Figure 59. Osteoarthritis Pain Drugs Value Chain
Figure 60. Channels of Distribution (Direct Vs Distribution)
Figure 61. Bottom-up and Top-down Approaches for This Report
Figure 62. Data Triangulation
Figure 63. Key Executives Interviewed
